PRPH - Utang jangka dawa perusahaan ProPhase

The market trend for ProPhase Labs, Inc. (PRPH) demonstrates long-term debt dynamics, which currently stand at 0.00. The business is vulnerable to trade conflicts and supply chain disruptions of Asian components. The company generates revenue from the sale of genetic tests and dietary supplements to US government agencies and private individuals. Strictly regulated express delivery routes for essential reagents ensure operational stability.

Portfolio managers evaluate the operating model of ProPhase Labs, Inc. (PRPH) through the lens of long-term liabilities, which measure the aggregate of loans and borrowings with maturities exceeding one year to analyze capital stability. By examining the history of the corporation's long-term loans and borrowings, investors can see how the debt load correlates with the costs of expensive CLIA certification, confirming the financial strength of the issuer's position.